Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection

被引：0
|
作者：
Wyles, David [1 ]
Weiland, Ola [2 ]
Yao, Betty [3 ]
Reindollar, Robert [4 ]
Weilert, Frank [5 ]
Dufour, Jean-Francois [6 ]
Gordon, Stuart [7 ]
Poordad, Fred [8 ]
Stoehr, Albrecht [9 ]
Brown, Ashley [10 ]
Mauss, Stefan [11 ]
Samanta, Suvajit [3 ]
Pilot-Matias, Tami [3 ]
Rodrigues, Lino, Jr. [3 ]
Trinh, Roger [3 ]
机构：
[1] Denver Hlth Med Ctr, Denver, CO USA
[2] Karolinska Univ Hosp Huddinge, Stockholm, Sweden
[3] AbbVie Inc, N Chicago, IL USA
[4] Piedmont HealthCare, Statesville, NC USA
[5] Waikato Hosp, Hamilton, New Zealand
[6] Inselspital Bern, Bern, Switzerland
[7] Henry Ford Hosp, Detroit, MI 48202 USA
[8] Univ Texas Hlth, Texas Liver Inst, San Antonio, TX USA
[9] IFI Studien & Projekte Gmbh, Hamburg, Germany
[10] Imperial Coll Healthcare NHS Trust, London, England
[11] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany
来源：
SWISS MEDICAL WEEKLY | 2018年 / 148卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H3
引用
收藏
页码：25S / 25S
页数：1
相关论文
共 50 条
  • [11] Glecaprevir plus pibrentasvir for treatment of hepatitis C
    Carrion, Andres F.
    Martin, Paul
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (04) : 413 - 419
  • [12] Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment
    Yap, Desmond Y. H.
    Liu, Kevin S. H.
    Hsu, Yu-Chun
    Wong, Grace L. H.
    Tsai, Ming-Chang
    Chen, Chien-Hung
    Hsu, Ching-Sheng
    Hui, Yee Tak
    Li, Michael K. K.
    Liu, Chen-Hua
    Kan, Yee-Man
    Yu, Ming-Lung
    Yuen, Man-Fung
    CLINICAL AND MOLECULAR HEPATOLOGY, 2020, 26 (04) : 554 - 561
  • [13] Efficacy and safety of glecaprevir/pibrentasvir in patients with hepatitis C virus infection aged ≥75 years
    Kinoshita, Akiyoshi
    Koike, Kazuhiko
    Mizuno, Yusuke
    Ogata, Itsuro
    Kobayashi, Yutaro
    Hasegawa, Kiyoshi
    Shiraishi, Koichi
    Yoshida, Hideo
    Nakata, Ryo
    Yamada, Norie
    Yasuda, Kiyomi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2020, 20 (06) : 578 - 583
  • [14] EFFECTIVENESS AND SAFETY OF GLECAPREVIR AND PIBRENTASVIR FOR HEMODIALYSIS PATIENTS WITH HEPATITIS C VIRUS INFECTION AT A SINGLE CENTER
    Hotta, Naoki
    GUT, 2020, 69 : A71 - A71
  • [15] Glecaprevir plus pibrentasvir for paediatric hepatitis C infection
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (06): : 428 - 428
  • [16] A possible case of maculopapular eruption associated with glecaprevir/pibrentasvir treatment for chronic hepatitis C virus infection
    Tomiyasu, Hiroka
    Nakajima, Saeko
    Kaku, Yo
    Hirata, Masahiro
    Kataoka, Tatsuki
    Nomura, Takashi
    Kabashima, Kenji
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2021, 4 (04) : 93 - 95
  • [17] Glecaprevir/Pibrentasvir Treatment in a Patient with Hemophilia and Mixed Genotype Hepatitis C Infection
    Karasahin, Omer
    Karasahin, Emine Fusun
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2021, 27 (03): : 159 - 161
  • [18] Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection
    Goki Suda
    Chitomi Hasebe
    Masami Abe
    Masayuki Kurosaki
    Jun Itakura
    Namiki Izumi
    Yoshihito Uchida
    Satoshi Mochida
    Hiroaki Haga
    Yoshiyuki Ueno
    Kazumichi Abe
    Atsushi Takahashi
    Hiromasa Ohira
    Yoko Tsukuda
    Ken Furuya
    Masaru Baba
    Yoshiya Yamamoto
    Tomoe Kobayashi
    Jun Inoue
    Katsumi Terasita
    Masatsugu Ohara
    Naoki Kawagishi
    Takaaki Izumi
    Masato Nakai
    Takuya Sho
    Mitsuteru Natsuizaka
    Kenichi Morikawa
    Koji Ogawa
    Naoya Sakamoto
    Journal of Gastroenterology, 2019, 54 : 641 - 649
  • [19] Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection
    Suda, Goki
    Hasebe, Chitomi
    Abe, Masami
    Kurosaki, Masayuki
    Itakura, Jun
    Izumi, Namiki
    Uchida, Yoshihito
    Mochida, Satoshi
    Haga, Hiroaki
    Ueno, Yoshiyuki
    Abe, Kazumichi
    Takahashi, Atsushi
    Ohira, Hiromasa
    Tsukuda, Yoko
    Furuya, Ken
    Baba, Masaru
    Yamamoto, Yoshiya
    Kobayashi, Tomoe
    Inoue, Jun
    Terasita, Katsumi
    Ohara, Masatsugu
    Kawagishi, Naoki
    Izumi, Takaaki
    Nakai, Masato
    Sho, Takuya
    Natsuizaka, Mitsuteru
    Morikawa, Kenichi
    Ogawa, Koji
    Sakamoto, Naoya
    Yoshida, Junichi
    Nagasaka, Atsushi
    Fuzinaga, Akira
    Kikuchi, Hideaki
    Atarashi, Tomofumi
    Furuya, Ken
    Muto, Shuichi
    Meguro, Takashi
    Saga, Akiyoshi
    Okamoto, Munenori
    Katagiri, Masaki
    Miyagishima, Takuto
    Konno, Jun
    Kumagai, Kenichi
    Onodera, Manabu
    Kobayashi, Tomoe
    Uebayashi, Minoru
    Katou, Kanji
    Kunieda, Yasuyuki
    Tateyama, Miki
    Kawakami, Atsuhiko
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (07) : 641 - 649
  • [20] Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection
    Toyoda, Hidenori
    Chayama, Kazuaki
    Suzuki, Fumitaka
    Sato, Ken
    Atarashi, Tomofumi
    Watanabe, Tsunamasa
    Atsukawa, Masanori
    Naganuma, Atsushi
    Notsumata, Kazuo
    Osaki, Yukio
    Nakamuta, Makoto
    Takaguchi, Koichi
    Saito, Satoru
    Kato, Koji
    Pugatch, David
    Burroughs, Margaret
    Redman, Rebecca
    Alves, Katia
    Pilot-Matias, Tami J.
    Oberoi, Rajneet K.
    Fu, Bo
    Kumada, Hiromitsu
    HEPATOLOGY, 2018, 67 (02) : 505 - 513
12345